Clinical trials
Hyperoxaluria trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 4 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Recruiting | 8 |
| Terminated | 3 |
| Withdrawn | 3 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 13 |
| Allena Pharmaceuticals | 6 |
| Alnylam Pharmaceuticals | 4 |
| OxThera | 4 |
| Aga Khan University | 2 |
| Hospices Civils de Lyon | 2 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| University of Alabama at Birmingham | 2 |
| YolTech Therapeutics Co., Ltd | 2 |
| BioMarin Pharmaceutical | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperoxaluria | 48 |
| Hyperoxaluria, Primary | 21 |
| Kidney Calculi | 15 |
| Nephrolithiasis | 9 |
| Kidney Diseases | 7 |
| Urologic Diseases | 7 |
| Urolithiasis | 6 |
| Cystinuria | 4 |
| Dent Disease | 4 |
| Genetic Diseases, Inborn | 3 |
Trials
Showing 26 to 48 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.